NCT04576039View on ClinicalTrials.gov

Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Uterine FibroidEndometrial Cyst
Interventions
DIAGNOSTIC_TEST

saline infusion sonography

Instillation of 10cc of saline infusion in the uterine cavity while performing an ultrasonic evaluation of the uterine cavity and endometrium.

Trial Locations (1)

1090

Universitair Ziekenhuis UZBrussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT04576039 - Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes | Biotech Hunter | Biotech Hunter